SentiSense
Ctrl+K
Quick tip: Press
to search stocks
M
MRNA
Moderna Inc.
$52.52
-1.31 (-2.43%)
Summary
Stories
News
Metrics
Fundamentals
Current Market Valuation
Current Price
$52.52
Live market price
P/E (TTM)
N/A
Negative earnings
P/S (TTM)
10.67
Price to Sales
TTM Quarters
4
Quarters included in TTM
Updated: 3/8/2026, 10:24:03 PM
Historical Trends
Range:
Revenue Over Time
Net Income Over Time
Short Interest (% of Float) Over Time
Short Interest
71.3M
% of Float
20.6%
Days to Cover
6.5
Avg Daily Vol
10.9M
Historical income statement data up to 5 years
Historical SEC Filings
Report Period
Debt/Equity
0.20
Leverage ratio
ROE (TTM)
-32.62%
Return on equity
Income Statement
Revenue
$1.94B
Cost of Revenue
$868.00M
Gross Profit
$1.08B
Operating Income
$-3.07B
Net Income
$-2.82B
EPS (Quarter)
$-7.26
EPS (TTM)
--
Balance Sheet
Total Assets
$12.34B
Total Liabilities
$3.69B
Shareholders' Equity
$8.65B
Current Assets
$6.54B
Current Liabilities
$1.99B
Cash & Equivalents
--
Long-Term Debt
--
Cash Flow
Operating Cash Flow
$-1.87B
Investing Cash Flow
$1.95B
Financing Cash Flow
$593.00M
Free Cash Flow
$73.00M
Profitability Margins
Gross Margin
55.35%
Operating Margin
-158.13%
Net Profit Margin
-145.16%
ROA (TTM)
-22.87%
ROE (TTM)
-32.62%
Data source: Polygon.io
Last updated: 3/8/2026, 10:24:04 PM
Company Profile
Symbol
MRNA
Market Cap
$20.74B
IPO Date
Dec 7, 2018
CEO
Stéphane Bancel
Employees
4,700
Sector
--
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Country
United States
Exchange
--
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Read MoreSimilar Stocks
PFE
Pfizer Inc.
$27.05
+1.65%
NVS
Novartis AG
$160.12
-0.55%